AKINCI, B. Et Al. 2008. Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.81, no.1 , 93-96.

AKINCI, B., DEMİR, T., Saygili, S., Yener, S., ALACACIOĞLU, İ., Saygili, F., ... BAYRAKTAR, F.(2008). Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.81, no.1, 93-96.

AKINCI, BARIŞ Et Al. "Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy," DIABETES RESEARCH AND CLINICAL PRACTICE , vol.81, no.1, 93-96, 2008

AKINCI, BARIŞ Et Al. "Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.81, no.1, pp.93-96, 2008

AKINCI, B. Et Al. (2008) . "Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.81, no.1, pp.93-96.

@article{article, author={BARIŞ AKINCI Et Al. }, title={Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy}, journal={DIABETES RESEARCH AND CLINICAL PRACTICE}, year=2008, pages={93-96} }